Treatment for extreme nausea, vomiting during pregnancy

May 06, 2009

Nausea and vomiting are telltale indicators of pregnancy, affecting more than 80 percent of future mothers. For a few moms-to-be, symptoms can become so severe that hospitalization is required.

Yet a new medication protocol, introduced by the Sainte-Justine University Center, appears effective in improving symptoms more quickly and provides a safer option than those previously available. The findings, which are good news for moms and babies, are published in a recent edition of the European Journal of Obstetrics and Gynecology and Reproductive Biology.

"In 2002, we had to quickly change the medication protocol to treat hyperemisis gravidarum (HG), or severe nausea and vomiting of pregnancy, due to a FDA and Health Canada warnings," says senior researcher Anick Bérard, a professor at the Université de Montréal's Faculty of Pharmacy and director of the Research Unit on Medications and Pregnancy of the Sainte-Justine University Hospital Center.

"The warning found that a previously used anti-vomiting medication might cause adverse cardiovascular effects in mothers. We had to quickly choose another treatment, which was safer. The current study looks back at the data to evaluate the effectiveness of this treatment."

Metoclopramide versus droperidol

Dr. Bérard and her team, which included researchers from the Université de Bourgogne, evaluated 229 who were admitted to hospital and treated for HG. The scientists compared use of the standard drug droperidol versus the administration of a newer medication called metoclopramide.

They found that metoclopramide worked faster to quell symptoms of nausea and vomiting than droperidol. Importantly, they found no evidence that either of these medications increased the birth defect rate compared to women who received no medication. As expected, metoclopramide was not associated with other serious side effects.

"This study validates our protocol," says Dr. Bérard. "Clinical trials are not conducted on pregnant women, so we had to rely on data from prospective and retrospective studies in this case. We anticipate that other institutions will now be comfortable adopting this new treatment regime.

About hyperemis gravidarum

Hyperemis gravidarum, or severe nausea and vomiting of pregnancy, affects about one percent of pregnant women. If left untreated, it can result in severe weight loss, dehydration, or death. Symptoms to look out for include severe and ; incapacity to keep food down for two to three days; lack of energy.

According to Dr. Bérard, women should not wait too long before seeking help. "The longer the symptoms continue, the longer the hospital stay," she says, adding most women with HG leave the hospital within three days and many are required to take medication throughout their .

About the study:

"Metoclopramide and diphenhydramine in the treatment of hyperemisis gravidarum: Effectiveness and predictors of rehospitalization," published in European Journal of Obstetrics and Gynecology and Reproductive Biology, was authored by Anais Lacasse, Ema Ferreira and Anick Bérard of the Université de Montréal and the Sainte-Justine University Centre and Amandine Lagoutte of the Université de Bourgogne.

Source: University of Montreal (news : web)

Explore further: Key element of CPR missing from guidelines

add to favorites email to friend print save as pdf

Related Stories

Smoking during pregnancy fosters aggression in children

Jan 06, 2009

Women who smoke during pregnancy risk delivering aggressive kids according to a new Canada-Netherlands study published in the journal Development and Psychopathology. While previous studies have shown that smoking during ...

Growing years cut short for toddlers from poor families

Jan 21, 2009

Continuous poverty during toddler years can curb the height of children by the time they reach kindergarten, even in industrialized countries, according to new research from the Université de Montréal. Regardless ...

Scientists discover gene responsible for brain's aging

Jan 16, 2009

Will scientists one day be able to slow the aging of the brain and prevent diseases such as Alzheimer's and Parkinson's? Absolutely - once the genetic coding associated with neuronal degeneration has been unraveled.

Impact of narcotics is greater on mentally ill

Feb 06, 2009

Narcotics have an irreversible effect on the brains of people already suffering from mental illness, according to Dr. Stéphane Potvin of the Université de Montréal affiliated Centre de recherche Fernand-Seguin ...

Recommended for you

Exploring 3-D printing to make organs for transplants

2 hours ago

Printing whole new organs for transplants sounds like something out of a sci-fi movie, but the real-life budding technology could one day make actual kidneys, livers, hearts and other organs for patients ...

High frequency of potential entrapment gaps in hospital beds

3 hours ago

A survey of beds within a large teaching hospital in Ireland has shown than many of them did not comply with dimensional standards put in place to minimise the risk of entrapment. The report, published online in the journal ...

Key element of CPR missing from guidelines

Jul 29, 2014

Removing the head tilt/chin lift component of rescue breaths from the latest cardiopulmonary resuscitation (CPR) guidelines could be a mistake, according to Queen's University professor Anthony Ho.

Burnout impacts transplant surgeons (w/ Video)

Jul 28, 2014

Despite saving thousands of lives yearly, nearly half of organ transplant surgeons report a low sense of personal accomplishment and 40% feel emotionally exhausted, according to a new national study on transplant surgeon ...

User comments : 0